Mamoura Diversified Global Holding PJSC, 10% Owner at RECURSION PHARMACEUTICALS, INC. (RXRX), bought 6,300 shares at $7.95 ($50K) on 2023-02-14, disclosed to the SEC on 2023-02-15.
Open-market purchase of $50k RXRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| RXRX | BUY | 2023-02-22 | $1.5M | — | Filing → |
| RXRX | BUY | 2023-02-17 | $674K | — | Filing → |
| RXRX | BUY | 2023-02-13 | $88K | — | Filing → |